Prothrombin complex concentrates: indications, contraindications, and risks: a task force summary. (Record no. 10457073)

MARC details
000 -LEADER
fixed length control field 01390 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513192916.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199911s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0049-3848
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/s0049-3848(99)00077-8
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Hellstern, P
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19991105
245 00 - TITLE STATEMENT
Title Prothrombin complex concentrates: indications, contraindications, and risks: a task force summary.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Thrombosis research
Date of publication, distribution, etc. Aug 1999
300 ## - PHYSICAL DESCRIPTION
Extent S3-6 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Blood Coagulation Factors
General subdivision standards
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Coagulation Protein Disorders
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Contraindications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disseminated Intravascular Coagulation
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heparin
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Liver Diseases
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prothrombin
General subdivision standards
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Reference Standards
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thrombocytopenia
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vitamin K Deficiency
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Halbmayer, W M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Köhler, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Seitz, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Müller-Berghaus, G
773 0# - HOST ITEM ENTRY
Title Thrombosis research
Related parts vol. 95
-- no. 4 Suppl 1
-- p. S3-6
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/s0049-3848(99)00077-8">https://doi.org/10.1016/s0049-3848(99)00077-8</a>
Public note Available from publisher's website

No items available.